• Browse By Topic

  • White Papers

    • Found in translation

    • The cost of drug production has soared into the billions, presenting a huge barrier to companies hoping to market new medicines and creating a pressing need for more efficient development techniques.
    • Authors: Dan WeaverJens Hoefkens, Ph.D. , Company: PerkinElmer Informatics
      • Printer Friendly Bookmark
        • Be the first to rate it!
        • Please Login to rate
  • PerkinElmer’s Jens Hoefkens and Daniel Weaver discuss how translational medicine is simultaneously reducing expenses and improving the health of patients.